DAA408 |
CDC42 effector protein (Rho GTPase binding) 3 |
CDC42EP3 |
6.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA462 |
CDK5 regulatory subunit associated protein 3 |
CDK5RAP3 |
4.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA95 |
cell division cycle 2-like 2 (PITSLRE proteins) |
CDC2L2 |
27.0% Increase Gene Expression Level |
brain |
Human |
|
DAA557 |
centromere protein V |
CENPV |
4.0% Decrease Gene Expression Level |
skeletal muscle |
Human |
|
DAA349 |
centrosomal protein 350kDa |
CEP350 |
4.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA2087 |
centrosomal protein 57kDa increases with age |
CEP57 |
86.0% Increase Gene Expression Level |
ovary |
Human |
|
DAA2405 |
chemokine (C-C motif) receptor 1 decreases with age |
CCR1 |
16.5% Decrease DNA Methylation |
dermis |
Human |
|
DAA2297 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
93.8% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2454 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
31.2% Increase DNA Methylation |
mesenchymal stem cell |
Human |
|
DAA2303 |
chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
53.9% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2302 |
Chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
129.2% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2296 |
Chemokine (C-C motif) receptor 1 increases with age |
CCR1 |
182.5% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
46.7% Decrease Gene Expression Level |
temporal lobe |
Human |
|
DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
58.0% Decrease Gene Expression Level |
frontal lobe |
Human |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
31.6% Decrease Gene Expression Level |
hippocampus |
Human |
|
DAA2307 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
61.1% Decrease Gene Expression Level |
frontal lobe |
Human |
|
DAA2305 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
56.2% Decrease Gene Expression Level |
parietal lobe |
Human |
|
DAA2304 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
CX3CL1 |
61.0% Decrease Gene Expression Level |
parietal lobe |
Human |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
CXCL12 |
30.9% Decrease Gene Expression Level |
hippocampus |
Human |
|
DAA2309 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
44.1% Increase Gene Expression Level |
frontal lobe |
Human |
|
DAA2306 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
78.9% Increase Gene Expression Level |
parietal lobe |
Human |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
CXCL16 |
100.6% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
CXCL5 |
64.9% Increase Gene Expression Level |
hippocampus |
Human |
|
DAA305 |
chemokine-like factor |
CKLF |
4.0% Increase Gene Expression Level |
skeletal muscle |
Human |
|
DAA43 |
chimerin (chimaerin) 1 |
CHN1 |
6.0% Decrease Gene Expression Level |
brain |
Human |
|